CMS Open Payments · Program Year 2024
Polarean, Inc.
Polarean, Inc. reported $206,642.97 across General Payments, Research, and Ownership to 40 physicians and teaching hospitals across 42 transactions.
- $206.6K Below-median payer
- All-tracks total
- 42 Below-median volume
- Transactions
- 40 Below-median reach
- Recipients
- +$75.7K
- General Payments vs PY2023
Polarean, Inc. reported $206,642.97 across all CMS Open Payments tracks (General + Research + Ownership) to 40 physicians and teaching hospitals in Program Year 2024 - ranking #990 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $131,403.17, averaging $5.2K per recipient.
How Polarean, Inc.'s $206.6K all-tracks total breaks down
Polarean, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
12/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer polarean-inc Polarean, Inc.
$206.6K · #990/1,925 · 0.0% industry · PY2024
- TOT $206.6K
- RANK #990
- SHARE 0.0%
- TXN 42
- RCP 40
- CAT 5
- GEN $131.4K
- ΔGEN +$75.7K
- TOP1 45.8%
- PY 2024
Volume peers
Nearest volume peer: Synapse Biomedical Inc ($207.4K)
Polarean, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Polarean, Inc.'s CMS-reported General Payments increased by $75.7K (+136.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: POLAREAN, INC.PY2024: Polarean, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $55,655.09
- PY2024
- $131,403.17
What the Data Shows for Polarean, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Polarean, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
4 transactions worth $65.0K make "Space Rental or Facility Fees" the top general-payment category in the 5-category breakdown below, 49.5% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 5 types of general payments, Polarean, Inc.'s largest category was "Space Rental or Facility Fees" at $65.0K - 49.5% of General Payments.
Polarean, Inc. reports 5 general-payment categories - the top three are Space Rental or Facility Fees (49.5%), Consulting Fee (47.1%), and Travel and Lodging (1.6%). The remaining 2 categories make up 1.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Polarean, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Space Rental or Facility Fees | $65.0K | 4 | 49.5% |
| Consulting Fee | $61.9K | 10 | 47.1% |
| Travel and Lodging | $2.0K | 2 | 1.6% |
| Food and Beverage | $1.4K | 23 | 1.1% |
| Grant | $1.0K | 1 | 0.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $130,280.53 (99.1%) of $131,403.17 in this company's General Payments records across 24 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Polarean, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
University Of Iowa Hosp & Clinics
$60,140.00 across 2 reported transactions
- 2
Chase Hall
$50,245.93 across 10 reported transactions
- 3
Joseph Mammarappallil
$11,218.96 across 2 reported transactions
- 4
Childrens Hospital Medical Center
$5,884.39 across 3 reported transactions
- 5
Gerald Klein
$2,791.25 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Polarean, Inc. ranks #990 of 1,925 by total payments (bottom 49% by spend) but is notably more concentrated than that alone would suggest -- #483 of 1,838 by HHI (top 26% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- One Lambda, Inc. : $150.1K total payments, HHI 3711
- Nurami Medical Ltd : $627.48 total payments, HHI 3707
- Pristine Surgical LLC : $19.0K total payments, HHI 3684
- Circle Cardiovascular Imaging Inc. : $14.6K total payments, HHI 3678
- Merakris Therapeutics, Inc. : $10.4K total payments, HHI 3674
- aap Implants Inc : $631.69 total payments, HHI 3671
- Polarean, Inc. (this company) : $131.4K total payments, HHI 3654
- AccuTec Blades Inc : $45.1K total payments, HHI 3645
- Epizyme, Inc. : $16.4K total payments, HHI 3641
- OrphAI Therapeutics Inc. : $24.4K total payments, HHI 3624
- Flume Catheter Company Inc. : $15.0K total payments, HHI 3600
- Skeletal Dynamics Inc : $2.8M total payments, HHI 3598
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Polarean, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Polarean, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Polarean, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Maquet Cardiopulmonary GmbH
ITF Therapeutics LLC
Diagnostica Stago, Inc
Austin Medical Ventures Inc
Mindray DS USA, Inc.
Put this to use
Polarean, Inc. ranks #990 of 1,925 by all-tracks total payments, led by "Space Rental or Facility Fees".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Space Rental or Facility Fees" spend across every manufacturer, not just Polarean, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.